SB220025 is an orally available, selective and potent inhibitor of P38 mitogen-activated protein kinase that inhibits p56Lck and PKC, inhibits endothelial growth hormone-induced Ca(2+) signaling, and inhibits angiogenesis, and can be used in the study of arthritis.
Molecular Weight:
338.38
Purity:
99.44%
CAS Number:
[165806-53-1]
Formula:
C18H19FN6
Target:
Src|||PKC|||p38 MAPK
T28681
T28681
* VAT and and shipping costs not included. Errors and price changes excepted
